Matching-adjusted indirect comparison between garadacimab and lanadelumab for the long-term prophylactic treatment of patients with hereditary angioedema

Matching-adjusted indirect comparison between garadacimab and lanadelumab for the long-term prophylactic treatment of patients with hereditary angioedema

Aim: This study aimed to estimate the relative efficacy between garadacimab 200 mg once monthly (200 QM) and two dosing regimens of lanadelumab (300 mg once every 2 weeks [300 Q2W] and 300 mg once every 4 weeks [300 Q4W]) in adolescent/adult patients with hereditary angioedema (HAE) using matchin...

Full description

Saved in:
Bibliographic Details
Main Authors: Sarah Walsh, Anja Haltner, Meaghan Bartlett, John Sears, Yinglei Li, Maebh Kelly, Simona Gavata-Steiger, Chiara Nenci, Iris Jacobs, Ingo Pragst, Neelanjana Ray, Imtiaz A Samjoo
Format: Article
Language:English
Published: Becaris Publishing Limited 2025-07-01
Series:Journal of Comparative Effectiveness Research
Subjects:
comparative evidence
garadacimab
hereditary angioedema
matching-adjusted indirect comparison
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items